Real-time enrollment status for this hiv-1-infection clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 3:40 AM UTC
| NCT Number | NCT06749054 |
| Recruiting Status | Recruiting |
| Condition | HIV-1-infection |
| Phase | PHASE2 |
| Target Enrollment | 12 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Gilead Sciences |
| Last Updated on CT.gov | April 24, 2026 (Apr 24, 2026) |
As of July 17, 2026: Clinical trial NCT06749054 is currently recruiting participants. This phase2 study for hiv-1-infection is actively seeking new participants at 1 location across the United States. The study is sponsored by Gilead Sciences. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06749054 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06749054 was last updated Apr 24, 2026 (April 24, 2026). HelloStudys verifies this status automatically.